U.S. flag

An official website of the United States government

NM_001184880.2(PCDH19):c.2728G>T (p.Glu910Ter) AND Developmental and epileptic encephalopathy, 9

Germline classification:
Pathogenic/Likely pathogenic (2 submissions)
Last evaluated:
Aug 9, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001885229.5

Allele description [Variation Report for NM_001184880.2(PCDH19):c.2728G>T (p.Glu910Ter)]

NM_001184880.2(PCDH19):c.2728G>T (p.Glu910Ter)

Gene:
PCDH19:protocadherin 19 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq22.1
Genomic location:
Preferred name:
NM_001184880.2(PCDH19):c.2728G>T (p.Glu910Ter)
HGVS:
  • NC_000023.11:g.100342023C>A
  • NG_021319.1:g.73251G>T
  • NM_001105243.2:c.2587G>T
  • NM_001184880.2:c.2728G>TMANE SELECT
  • NM_020766.3:c.2584G>T
  • NP_001098713.1:p.Glu863Ter
  • NP_001171809.1:p.Glu910Ter
  • NP_065817.2:p.Glu862Ter
  • LRG_843t1:c.2728G>T
  • LRG_843:g.73251G>T
  • LRG_843p1:p.Glu910Ter
  • NC_000023.10:g.99597021C>A
  • NM_001184880.1:c.2728G>T
Protein change:
E862*
Links:
dbSNP: rs2147485081
NCBI 1000 Genomes Browser:
rs2147485081
Molecular consequence:
  • NM_001105243.2:c.2587G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001184880.2:c.2728G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_020766.3:c.2584G>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Developmental and epileptic encephalopathy, 9 (DEE9)
Synonyms:
EPILEPSY, FEMALE-RESTRICTED, WITH MENTAL RETARDATION; JUBERG-HELLMAN SYNDROME; PCDH19-Related X-Linked Female-Limited Epilepsy with Mental Retardation; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0010246; MedGen: C1848137; Orphanet: 2076; OMIM: 300088

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002038584Stanford Center for Inherited Cardiovascular Disease, Stanford University
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenicde novoclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002133136Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Aug 9, 2022)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
Asiande novoyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Mutations and deletions in PCDH19 account for various familial or isolated epilepsies in females.

Depienne C, Trouillard O, Bouteiller D, Gourfinkel-An I, Poirier K, Rivier F, Berquin P, Nabbout R, Chaigne D, Steschenko D, Gautier A, Hoffman-Zacharska D, Lannuzel A, Lackmy-Port-Lis M, Maurey H, Dusser A, Bru M, Gilbert-Dussardier B, Roubertie A, Kaminska A, Whalen S, Mignot C, et al.

Hum Mutat. 2011 Jan;32(1):E1959-75. doi: 10.1002/humu.21373.

PubMed [citation]
PMID:
21053371
PMCID:
PMC3033517
See all PubMed Citations (3)

Details of each submission

From Stanford Center for Inherited Cardiovascular Disease, Stanford University, SCV002038584.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1Asiannot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyesnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002133136.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1328937). This variant has not been reported in the literature in individuals affected with PCDH19-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu910*) in the PCDH19 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PCDH19 are known to be pathogenic (PMID: 21053371).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024